A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants

A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (Liq) and Tritanrix + Hiberix (Lyo) in Indian infants administered according to the EPI schedule

(2014) Raman Rao et al.   Human vaccines & immunotherapeutics

Why Do Pertussis Vaccines Fail?

(2012) J. D. Cherry   PEDIATRICS

Development and introduction of a ready-to-use pediatric pentavalent vaccine to meet and sustain the needs of developing countries – Quinvaxem®: The first 5 years

(2012) D.A. Schmid et al.   VACCINE

Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem®demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine

(2012) Sanet Aspinall et al.   Human Vaccines & Immunotherapeutics

Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children

(2011) Hitt J. Sharma et al.   Human vaccines & immunotherapeutics

A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants

(2011) Hitt Sharma et al.   VACCINE

The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule

(2010) Sukanta Chatterjee et al.   BMC INFECTIOUS DISEASES

Immunogenicity and reactogenicity of a combined fully liquid DTPw–HepB–Hib pentavalent vaccine in healthy infants: no clinically relevant impact of a birth dose of hepatitis B vaccine

(2010) Angela Gentile et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES